FDA Inspection 882728 — Anthony Joshua MD
The FDA completed an inspection of Anthony Joshua MD on June 6, 2014 in Toronto. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 6, 2014
- Fiscal Year
- 2014
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Toronto (Canada)
Additional Details
Clinical Investigator (CI)